Switching from serotonin reuptake inhibitors to agomelatine in patients with refractory obsessive-compulsive disorder: a 3 month follow-up case series

BACKGROUND: Serotonin reuptake inhibitors (SRIs) currently represent the cornerstone of obsessive-compulsive disorder (OCD) pharmacotherapy. However, OCD is characterized by high rates of partial and/or absent response to standard, recommended treatments, often prompting pharmacological and non-phar...

Descripción completa

Detalles Bibliográficos
Autor principal: Fornaro, Michele
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058071/
https://www.ncbi.nlm.nih.gov/pubmed/21356085
http://dx.doi.org/10.1186/1744-859X-10-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3058071/
https://www.ncbi.nlm.nih.gov/pubmed/21356085
http://dx.doi.org/10.1186/1744-859X-10-5

Ejemplares similares